As studies increasingly correlate SMARCA4 with lung cancer treatment and prognosis, the accurate identification of SMARCA4-deficient tumor subtype becomes critical and may necessitate specific therapeutic strategies. The gene discussed is SMARCA4; the disease is lung carcinoma.